医学
吉西他滨
无容量
内科学
临床终点
不利影响
胰腺癌
中止
胃肠病学
癌症
肿瘤科
外科
临床试验
免疫疗法
作者
Zev A. Wainberg,Howard S. Höchster,Edward Kim,Ben George,Aparna Kaylan,E. Gabriela Chiorean,David Waterhouse,Martin Guiterrez,Aparna R. Parikh,Rishi Jain,Daniel R. Carrizosa,Hatem Soliman,Thomas Lila,David J. Reiss,Daniel W. Pierce,Rafia Bhore,Sibabrata Banerjee,Larry Lyons,Chrystal U. Louis,Teng Jin Ong
标识
DOI：10.1158/1078-0432.ccr-20-0099
摘要
The safety profile of nivolumab plus nab-paclitaxel and gemcitabine at standard doses in advanced pancreatic cancer was manageable, with no unexpected safety signals. Overall, the clinical results of this study do not support further investigation.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
嘻嘻哈哈
Copyright
迷人的天抒
zzzz
ye
无情的聪健
MchemG
ming2026
Nole
Momomo
Bi8bo626
Alex
專注完美近乎苛求
文LL
破忒头
皖公网安备34019202002308
